Skip to content

Report a Typo or Mistake

Optional

Optional

Optional

Bristol Myers Squibb acquires Karuna Therapeutics for $14 billion, boosting neuroscience portfolio
https://www.newwestrecord.ca/health/bristol-myers-squibb-acquires-karuna-therapeutics-for-14-billion-boosting-neuroscience-portfolio-8022514
Verify